Peregrine Ventures held a final close of Peregrine 4 with $115 million in committed capital, the firm announced on Monday. Fund 4 follows a $75 million close two years ago of the firm’s prior vehicle, Peregrine 3.
The firm invests in Israeli technology businesses in the medical, biotech and life sciences sectors. Peregrine has completed 10 exits from its three prior funds since being founded in 2001.
The fundraise brings the firm’s assets under management to $200 million, with an additional $200 million available for co-investments, follow-on capital, and late stage investments in the firm’s portfolio companies, Peregrine Ventures said in a statement.